XML 30 R15.htm IDEA: XBRL DOCUMENT v3.22.2.2
Note I - Stockholders' Equity
12 Months Ended
Jun. 30, 2022
Notes to Financial Statements  
Stockholders' Equity Note Disclosure [Text Block]

I. Stockholders Equity

 

Treasury Stock

 

On September 18, 2020, the Board of Directors authorized a $2.0 million increase to our stock repurchase plan (“Repurchase Plan”), thus bringing the total authorized repurchase amount to $12.0 million. On March 12, 2021, the Board of Directors authorized an additional $3.0 million increase to the Repurchase Plan, thus bringing the total authorized repurchase amount to $15.0 million. On January 14, 2022, the Board of Directors authorized an additional $3.0 million increase to the Repurchase Plan, thus bringing the total authorized repurchase amount to $18.0 million. Under the Repurchase Plan, we may, from time to time, purchase shares of our common stock, depending upon market conditions, in open market or privately negotiated transactions.

 

Treasury Stock repurchases for the year ended June 30, 2022 were as follows:

 

  

Shares

  

Average Cost

  

Total Cost (in thousands)

 

Shares purchased under Repurchase Plan

  406,817  $12.76  $5,190 

Shares acquired from employees for restricted stock vesting

  28,263   11.08   313 

Total

  435,080     $5,503 

 

Treasury Stock repurchases for the year ended June 30, 2021 were as follows:

 

  

Shares

  

Average Cost

  

Total Cost (in thousands)

 

Shares purchased under Repurchase Plan

  385,822  $8.28  $3,197 

Shares acquired in connection with stock option exercises

  30,442   9.95   303 

Shares acquired from employees for restricted stock vesting

  47,228   13.69   647 

Total

  463,492      $4,147 

 

Treasury stock repurchase costs include commissions and fees.

 

Shares acquired from employees for restricted stock vesting and stock options exercises were returned to us by the related employees and in return we paid each employee’s required tax withholding resulting from the vesting of restricted shares. The valuation of the shares acquired and thereby the number of shares returned to us was calculated based on the closing share price on the date the shares vested.

 

Stock Incentive Plans

 

For the year ended June 30, 2022, the Company had no stock options outstanding.

 

Stock option activity for the year ended June 30, 2021 was as follows:

 

  

2009
Plan

  

Weighted
Average
Exercise

Price

  

Weighted
Average
Contractual
Term
(in years)

  

Aggregate

Intrinsic
Value

 

Vested and exercisable at June 30, 2020

  130,000  $6.28         

Exercised

  (130,000

)

 $6.28         

Forfeited

    $         

Granted

    $         

Outstanding at June 30, 2021

    $     $ 

Vested and exercisable at June 30, 2021

    $     $ 

 

Of the 130,000 options exercised, 120,000 of these option exercises were cashless net exercises resulting in the issuance of 55,915 shares for the year ended June 30, 2021.

 

Restricted stock activity for the year ended June 30, 2022 was as follows:

 

  

Number of

Shares

2009 Plan

  

Weighted

Average Grant

Date Fair

Value

 

Nonvested at June 30, 2021

  61,324  $11.47 

Granted

    $ 

Vested

  (51,326

)

 $11.52 

Forfeited

  (8,332

)

 $10.88 

Nonvested at June 30, 2022

  1,666  $8.50 

Available for grant at June 30, 2022

       

 

  

Number of

Shares

2020 Plan

  

Weighted

Average Grant

Date Fair

Value

 

Nonvested at June 30, 2021

  87,773  $16.81 

Granted

  135,850  $10.99 

Vested

  (25,896

)

 $16.81 

Forfeited

  (11,500

)

 $16.81 

Nonvested at June 30, 2022

  186,227  $12.56 

Available for grant at June 30, 2022

  472,377     

 

Restricted stock activity for the year ended June 30, 2021 was as follows:

 

  

Number of

Shares

2009 Plan

  

Weighted

Average Grant

Date Fair

Value

 

Nonvested at June 30, 2020

  197,650  $11.06 

Granted

    $ 

Vested

  (136,326

)

 $10.88 

Forfeited

    $ 

Nonvested at June 30, 2021

  61,324  $11.47 

Available for grant at June 30, 2021

       

 

  

Number of

Shares

2020 Plan

  

Weighted

Average Grant

Date Fair

Value

 

Nonvested at June 30, 2020

    $ 

Granted

  91,773  $16.81 

Vested

  (4,000

)

 $16.81 

Forfeited

    $ 

Nonvested at June 30, 2021

  87,773  $16.81 

Available for grant at June 30, 2021

  608,227     

 

Restricted stock grants, granted to members of our Board of Directors and certain key members of our management team, vest over a period of years from the date of grant and the unvested shares cannot be sold or otherwise transferred and the right to receive dividends, if declared by our Board of Directors, is forfeitable until the shares become vested. The total remaining unrecognized compensation cost related to unvested restricted stock shares amounted to $2.1 million at June 30, 2022 and the weighted average remaining requisite service period of unvested restricted stock shares was 2.4 years.